Hi-Tech DMAA Ruling, Recalls: Health And Wellness Industry News
This article was originally published in The Rose Sheet
Executive Summary
HiTech Pharmaceuticals will appeal ruling dismissing its complaint against FDA's seizure of its DMAA supplements; and Butala Emporium's Baidyanath brand products and McShare's Premark HS Vitamin RDA Premix are among recent recalls in the dietary supplement sector.
You may also be interested in...
Biotin And ‘Healthy Hair’: Federal Pre-emption Clips False Advertising Complaint In California
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
Hi-Tech Tangles With FDA Again: Plans Litigation To Keep DMHA Available
Hi-Tech Pharmaceuticals says it will "continue to supply its customers with DMHA-containing products until there is a final, judicial determination." Firm, currently appealing a ruling upholding a previous FDA action, says DMHA "is a stimulant compound naturally found in Walnut Bark extract" and walnuts "are the oldest tree food known to man."
FDA Closes Another Business Smuggling Drugs From China As Dietary Ingredients
Importer Pure Assay Ingredients, owners Lynn Chau and Bao Luu charged in seven-count indictment with conspiring to deceive US Customs with stimulants labeled as melatonin, sucralose or other dietary ingredients. Also charged are two Chinese citizens who worked for Pure Assay in Chengdu, China, to bring the illegal substances to the US.